Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results.

Samuel A. Funt, Rohit K. Jain, Xīn Gào et al.|Journal of Clinical Oncology|2024

Cited by 2